Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 102

Publication Record

Connections

Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
Chung JR, Kim SS, Kondor RJ, Smith C, Budd AP, Tartof SY, Florea A, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Reis M, Geffel KM, Nowalk MP, DaSilva J, Keong LM, Stark TJ, Barnes JR, Wentworth DE, Brammer L, Burns E, Fry AM, Patel MM, Flannery B
(2022) MMWR Morb Mortal Wkly Rep 71: 365-370
MeSH Terms: Adolescent, Adult, Aged, Child, Child, Preschool, Humans, Infant, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Influenza A virus, Influenza B virus, Influenza Vaccines, Influenza, Human, Middle Aged, Population Surveillance, Seasons, United States, Vaccination, Vaccine Efficacy
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
Tenforde MW, Self WH, Adams K, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, Mohr NM, Zepeski A, Shapiro NI, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Exline MC, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL, Busse LW, Ten Lohuis CC, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Rhoads JP, Lindsell CJ, Hart KW, Zhu Y, Olson SM, Kobayashi M, Verani JR, Patel MM, Influenza and Other Viruses in the Acutely Ill (IVY) Network
(2021) JAMA 326: 2043-2054
MeSH Terms: 2019-nCoV Vaccine mRNA-1273, Adult, Aged, BNT162 Vaccine, COVID-19, COVID-19 Vaccines, Case-Control Studies, Disease Progression, Female, Hospitalization, Humans, Male, Middle Aged, Respiration, Artificial, SARS-CoV-2, Severity of Illness Index, Vaccination
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
Tenforde MW, Self WH, Naioti EA, Ginde AA, Douin DJ, Olson SM, Talbot HK, Casey JD, Mohr NM, Zepeski A, Gaglani M, McNeal T, Ghamande S, Shapiro NI, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Gong MN, Mohamed A, Henning DJ, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL, Busse LW, Ten Lohuis CC, Duggal A, Wilson JG, Gordon AJ, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Exline MC, Halasa N, Chappell JD, Lauring AS, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Lindsell CJ, Hart KW, Zhu Y, Stephenson M, Schrag SJ, Kobayashi M, Verani JR, Patel MM, IVY Network Investigators, IVY Network
(2021) MMWR Morb Mortal Wkly Rep 70: 1156-1162
MeSH Terms: Adolescent, Adult, Aged, COVID-19, COVID-19 Vaccines, Female, Hospitalization, Humans, Male, Middle Aged, Time Factors, United States, Vaccination, Vaccines, Synthetic, Young Adult
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.
Lytle KL, Collins SP, Feldstein LR, Baughman AH, Brown SM, Casey JD, Erickson HL, Exline MC, Files DC, Gibbs KW, Ginde AA, Gong MN, Grijalva CG, Khan A, Lindsell CJ, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub JS, Stubblefield WB, Tenforde MW, Womack KN, Patel MM, Self WH, Influenza and Other Viruses in the Acutely Ill (IVY) Network
(2021) Vaccine 39: 5271-5276
MeSH Terms: Adult, Humans, Influenza Vaccines, Influenza, Human, United States, Vaccination
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
Grijalva CG, Feldstein LR, Talbot HK, Aboodi M, Baughman AH, Brown SM, Casey JD, Erickson HL, Exline MC, Files DC, Gibbs KW, Ginde AA, Gong MN, Halasa N, Khan A, Lindsell CJ, Nwosu SK, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub JS, Stubblefield WB, Tenforde MW, Patel MM, Self WH, Influenza and Other Viruses in the Acutely Ill (IVY) Network
(2021) Clin Infect Dis 73: 1459-1468
MeSH Terms: Adolescent, Adult, Aged, Case-Control Studies, Humans, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Influenza B virus, Influenza Vaccines, Influenza, Human, Middle Aged, Seasons, United States, Vaccination, Young Adult
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates.
Feldstein LR, Ferdinands JM, Self WH, Randolph AG, Aboodi M, Baughman AH, Brown SM, Exline MC, Clark Files D, Gibbs K, Ginde AA, Gong MN, Grijalva CG, Halasa N, Khan A, Lindsell CJ, Newhams M, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub J, Talbot HK, Halloran ME, Patel M
(2021) J Infect Dis 224: 2035-2042
MeSH Terms: Bias, Humans, Influenza Vaccines, Influenza, Human, Vaccination, Vaccine Efficacy
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
Sami S, Tenforde MW, Talbot HK, Lindsell CJ, Steingrub JS, Shapiro NI, Ginde AA, Douin DJ, Prekker ME, Erickson HL, Brown SM, Peltan ID, Gong MN, Khan A, Exline MC, Files DC, Gibbs KW, Rice TW, Casey JD, Grijalva CG, Stubblefield WB, Womack KN, Hager DN, Qadir N, Chang SY, Henning DJ, Wilson JG, Self WH, Patel MM
(2021) Clin Infect Dis 73: S32-S37
MeSH Terms: Adolescent, Adult, COVID-19, COVID-19 Vaccines, Hospitalization, Humans, SARS-CoV-2, United States, Vaccination
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
Tenforde MW, Olson SM, Self WH, Talbot HK, Lindsell CJ, Steingrub JS, Shapiro NI, Ginde AA, Douin DJ, Prekker ME, Brown SM, Peltan ID, Gong MN, Mohamed A, Khan A, Exline MC, Files DC, Gibbs KW, Stubblefield WB, Casey JD, Rice TW, Grijalva CG, Hager DN, Shehu A, Qadir N, Chang SY, Wilson JG, Gaglani M, Murthy K, Calhoun N, Monto AS, Martin ET, Malani A, Zimmerman RK, Silveira FP, Middleton DB, Zhu Y, Wyatt D, Stephenson M, Baughman A, Womack KN, Hart KW, Kobayashi M, Verani JR, Patel MM, IVY Network, HAIVEN Investigators
(2021) MMWR Morb Mortal Wkly Rep 70: 674-679
MeSH Terms: Aged, COVID-19, COVID-19 Vaccines, Female, Hospitalization, Humans, Male, Risk Assessment, Treatment Outcome, United States, Vaccination Coverage, Vaccines, Synthetic
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND).
Feldstein LR, Self WH, Ferdinands JM, Randolph AG, Aboodi M, Baughman AH, Brown SM, Exline MC, Files DC, Gibbs K, Ginde AA, Gong MN, Grijalva CG, Halasa N, Khan A, Lindsell CJ, Newhams M, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub J, Talbot HK, Halloran ME, Patel M, Influenza Vaccine Effectiveness in the Critically Ill (IVY) Investigators and the Pediatric Intensive Care Influenza Vaccine Effectiveness (PICFLU-VE) Investigators
(2021) Clin Infect Dis 72: 1669-1675
MeSH Terms: Bias, Case-Control Studies, Humans, Influenza Vaccines, Influenza, Human, Treatment Outcome, Vaccination
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Immune repertoire fingerprinting by principal component analysis reveals shared features in subject groups with common exposures.
Sevy AM, Soto C, Bombardi RG, Meiler J, Crowe JE
(2019) BMC Bioinformatics 20: 629
MeSH Terms: Adult, Antibodies, Cohort Studies, Fetal Blood, HIV Infections, High-Throughput Nucleotide Sequencing, Humans, Influenza, Human, Middle Aged, Principal Component Analysis, Vaccination
Added March 21, 2020
0 Communities
2 Members
0 Resources
MeSH Terms